期刊文献+

八珍汤加味预防宫颈癌放疗血液学毒副反应临床观察 被引量:3

A clinical observation of Eight-Treasure Decoction(increase the variety of Chinese herbalmedicines)prevent cervical cancer radiotherapy hematological toxicity
原文传递
导出
摘要 目的观察八珍汤加味对宫颈癌放疗引起的血液学毒副反应预防作用。方法选择124例宫颈癌放疗患者,均未预防性使用重组人粒细胞集落刺激因子、重组人促红细胞生成素、重组人促血小板生成素,分为治疗组和对照组,每组62例,治疗组放疗加服中药八珍汤加味,对照组放疗,同时服利可君片、鲨肝醇。结果治疗组白细胞(WBC)、血红蛋白(HGB)下降情况明显比对照组好。结论八珍汤加味对于宫颈癌放疗引起的WBC下降有显著预防作用,对宫颈癌放疗引起的HGB下降预防作用较明显,但两组比较差异无统计学意义;宫颈癌放疗引起的血小板降低例数较少,预防价值不大。 Objective To observed the Preventive effect of Eight-Treasure Decoction (increase the variety of Chinese herbal medicines)taking for cervical cancer radiotherapy hematological toxicity. Methods Selected 124 cases of cervical cancer patients receiving radiotherapy, no prophylactic use of recombinant human granulocyte colony stimulating factor (rhG-CSF), recombinant human erythropoietin (rhEPO), recombinant human thrombopoietin (rhTPO). Divided into treatment group and control group and evry group were 62 cases. Treatment group was received radiotherapy and Eight-Treasure Decoction (increase the variety of Chinese herbal medicines) ; control group with radiation while serving profitable Jun tablets, shark liver alcohol. Results In the treatment group WBC and hemoglobin (HGB) was decline better than the control group significantly. Conclusion Eight-Treasure Decoction (increase the variety of Chinese herbal medicines) had the function of prevention to decreas the WBC and HGB effect caused by radiation therapy on cervial cancer ignificantly, but no significant statistical difference. Cervical cancer radiotherapy-induced platelet (PLT) reduce the small number of cases so the prevention of value is little.
出处 《中国肿瘤临床与康复》 2011年第6期546-548,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 宫颈肿癌 放射疗法 八珍汤加味 血液学毒副反应 Uterine cervical neoplasms Radiotherapy Eight-Treasure Decoction ( increase the variety of Chinese herbal medicines) Hematologic toxicity
  • 相关文献

参考文献5

二级参考文献3

共引文献12

同被引文献50

  • 1余志华,刘丛.恶性血液病患者焦虑抑郁对免疫功能的影响及护理干预[J].中国实用护理杂志,2005,21(5):2-4. 被引量:36
  • 2马玉璋.中医妇科学[M].北京:中国中医药出版社,2005:497-503.
  • 3Briccoli A,Rocca M,Salone M,et al.High grade osteosarcoma of the extremities metastatic to the lung:long-term results in 323patients treated combining surgery and chemotherapy,1985-2005[J].Surg Oncol,2010,19(4):193-199.
  • 4Endo-Munoz L.,Cumming A.,Sommerville S.,et al.Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone[J].British journal of cancer,2010,103:73-81.
  • 5Jaffe N.Osteosarcbma:Review of the past,impact on the future.Thmerican experience[J].Cancer Treat Res,2010,152:239-262.
  • 6Mirabello,L,Troisi,R.J.&Savage,S.A.Osteosarcoma incidence and survival rates from 1973 to 2004:data from the Surveillance,Epidemiology,and End Results Program[J].Cancer,2009,115:1531-1543.
  • 7Parkes S.E.,Parke S.,Mangham D.C.,et al.Fifty years of paediatric malignant bone tumours in the West Midlands,UK,1957-2006:incidence,treatment and outcome[J].Paediatric and perinatal epidemiology,2010,24:470-478.
  • 8Meyers PA,Schwartz CL,Krailo MD,et al.Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overall survival:a report from the Children's Oncology Group[J].J Clin Oncol,2008,26(4):633-638.
  • 9Sampo M.,Koivikko M.,Taskinen M.,et al.Incidence,epidemiology and treatment results of osteosarcoma in Finland-a nationwide population-based study[J].Acta Oncol,2011,50:1206-1214.
  • 10Longhi A,Ferrari S,Bacci G,et al.Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma[J].Anticancer Drugs,2007,72(3-4):255-260.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部